Deep Track Capital, LP
CIK 1856083 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $6.9B
- Posisi
- 67
- Per tanggal
- 30 Juni 2026
#651 dari 9.443 berdasarkan nilai 13F · top 6.9%
Nilai portofolio QoQ: +12.2% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 39,61%
- Bobot 25 kepemilikan teratas
- 73,96%
- Posisi di atas 1%
- 33
- Jumlah posisi efektif
- 35,8
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 27,67% Perkiraan pembelian $1.797.974.228 · penjualan $2.345.166.731
Kepemilikan median: 3,0 kuartal Dilacak Q4 2024–Q2 2026 · 47,5% masih dipegang
- Posisi baru
- 19
- Meningkat
- 22
- Menurun
- 15
- Tertutup
- 15
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
- Terkait Orang di balik pengaju ini, jika kami dapat mencocokkannya.
Kinerja vs S&P 500
Tahunan: +67.9% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 93,2% · Opsi dikecualikan: 10,4%
Rincian sektor
Healthcare
95,4%
Lainnya/Tidak terpetakan
4,6%
Portofolio lengkap 67 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| GH Guardant Health, Inc. - Common Stock | $509.098.599 | 7,41% | 3.393.312 | $200.745.278 | Naik ×2 | ||
| IMVT Immunovant, Inc. - Common Stock | $359.914.548 | 5,24% | 9.341.151 | $73.584.588 | Turun ×1 | ||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $254.399.664 | 3,70% | 4.740.072 | $48.110.990 | Naik ×2 | ||
| PCVX Vaxcyte, Inc. - Common Stock | $249.959.000 | 3,64% | 4.300.000 | $86.000 | |||
| ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | $248.349.750 | 3,61% | 825.000 | Naik ×1 | |||
| MANE Veradermics, Incorporated Common Stock | $245.880.000 | 3,58% | 2.000.000 | $214.305.000 | Naik ×1 | ||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $230.786.378 | 3,36% | 3.666.768 | $-21.753.622 | Naik ×5 | ||
| NUVL Nuvalent, Inc. - Class A Common Stock | $220.240.267 | 3,21% | 1.783.322 | $79.235.873 | Naik ×1 | ||
| ALKS Alkermes plc - Ordinary Shares | $209.580.000 | 3,05% | 4.000.000 | $82.626.179 | Naik ×2 | ||
| OCUL Ocular Therapeutix, Inc. - Common Stock | $193.319.289 | 2,81% | 19.686.282 | $26.576.480 | |||
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $189.254.063 | 2,75% | 3.307.481 | $124.290.563 | Naik ×1 | ||
| NRIX Nurix Therapeutics, Inc. - Common stock | $187.686.398 | 2,73% | 7.736.455 | $89.335.116 | Naik ×1 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $183.297.420 | 2,67% | 1.926.000 | $83.519.763 | Turun ×3 | ||
| ALMS Alumis Inc. - Common Stock | $178.648.422 | 2,60% | 6.348.558 | $29.448.154 | Turun ×1 | ||
| IONS Ionis Pharmaceuticals, Inc. - Common Stock | $174.438.000 | 2,54% | 2.200.000 | $28.012.500 | Naik ×2 | ||
| CMPS COMPASS Pathways Plc - American Depository Shares | $172.085.168 | 2,50% | 12.161.496 | $104.832.095 | |||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $171.640.000 | 2,50% | 4.000.000 | $6.452.925 | Turun ×1 | ||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $171.339.000 | 2,49% | 700.000 | $-14.583.000 | Turun ×2 | ||
| GMAB Genmab A/S - American Depositary Shares | $155.205.500 | 2,26% | 5.650.000 | $56.920.502 | Naik ×1 | ||
| MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | $136.271.017 | 1,98% | 6.999.025 | $16.809.811 | Naik ×2 | ||
| Penerbit tidak dikenal (CUSIP: 423494103) | $132.304.876 | 1,93% | 3.602.093 | Naik ×1 | |||
| TNGX Tango Therapeutics, Inc. - Common Stock | $131.292.000 | 1,91% | 4.200.000 | $73.762.000 | Naik ×3 | ||
| DFTX Definium Therapeutics, Inc. - Common Shares | $129.360.000 | 1,88% | 2.750.000 | $72.660.000 | Turun ×1 | ||
| GRAL GRAIL, Inc. - Common Stock | $125.271.627 | 1,82% | 1.834.944 | $36.237.478 | Naik ×2 | ||
| BCAX Bicara Therapeutics Inc. - Common Stock | $121.729.000 | 1,77% | 4.100.000 | $40.925.875 | Naik ×3 | ||
| MAZE Maze Therapeutics, Inc. - Common Stock | $111.379.859 | 1,62% | 3.732.569 | $7.574.633 | Naik ×1 | ||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $109.365.809 | 1,59% | 2.939.151 | $68.637.995 | Naik ×1 | ||
| LBRX LB Pharmaceuticals Inc - Common Stock | $108.815.254 | 1,58% | 3.352.804 | $26.135.107 | |||
| MBX MBX Biosciences, Inc. - Common Stock | $95.637.809 | 1,39% | 1.732.569 | $13.324.374 | Turun ×2 | ||
| GHRS GH Research PLC - Ordinary Shares | $89.600.018 | 1,30% | 3.333.334 | ||||
| GMAB Genmab A/S - American Depositary Shares | $82.410.000 | 1,20% | 3.000.000 | Opsi beli | Naik ×1 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $77.400.000 | 1,13% | 2.000.000 | $38.910.000 | Naik ×2 | ||
| ATAI AtaiBeckley Inc. - Common Stock | $75.979.919 | 1,11% | 14.417.442 | $33.499.919 | Naik ×1 | ||
| UTHR United Therapeutics Corporation - Common Stock | $66.978.857 | 0,97% | 123.616 | Naik ×1 | |||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $66.712.800 | 0,97% | 3.610.000 | ||||
| VRDN Viridian Therapeutics, Inc. - Common Stock | $65.998.634 | 0,96% | 3.592.740 | $38.733.089 | Naik ×1 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $59.633.000 | 0,87% | 700.000 | $-30.948.431 | Turun ×3 | ||
| ALT Altimmune, Inc. - Common Stock | $58.520.000 | 0,85% | 19.250.000 | Naik ×1 | |||
| PSNL Personalis, Inc. - Common Stock | $53.600.000 | 0,78% | 4.000.000 | $34.490.000 | Naik ×1 | ||
| ACRS Aclaris Therapeutics, Inc. - Common Stock | $49.435.050 | 0,72% | 9.345.000 | $14.391.300 | |||
| CRMD CorMedix Inc. - Common Stock | $49.251.497 | 0,72% | 6.274.076 | $6.650.521 | |||
| WGS GeneDx Holdings Corp. - Class A Common Stock | $48.055.000 | 0,70% | 700.000 | Naik ×1 | |||
| HROW Harrow, Inc. - Common Stock | $41.153.430 | 0,60% | 969.000 | Naik ×1 | |||
| CRVS Corvus Pharmaceuticals, Inc. - Common Stock | $37.229.569 | 0,54% | 2.491.939 | $778.353 | Naik ×1 | ||
| SLDB Solid Biosciences Inc. - Common Stock | $35.614.969 | 0,52% | 3.565.062 | $9.946.523 | |||
| BEAM Beam Therapeutics Inc. - Common Stock | $34.320.000 | 0,50% | 1.000.000 | $14.761.170 | Naik ×1 | ||
| DYN Dyne Therapeutics, Inc. - Common Stock | $33.315.000 | 0,48% | 1.500.000 | $-2.945.000 | Turun ×2 | ||
| IMMX Immix Biopharma, Inc. - Common Stock | $28.610.250 | 0,42% | 2.775.000 | Naik ×1 | |||
| XFOR X4 Pharmaceuticals, Inc. - Common Stock | $27.453.795 | 0,40% | 5.878.757 | $1.271.515 | Turun ×1 | ||
| STTK Shattuck Labs, Inc. - Common Stock | $25.724.734 | 0,37% | 3.706.734 | Naik ×1 | |||
| MNKD MannKind Corporation - Common Stock | $25.560.000 | 0,37% | 6.000.000 | Naik ×1 | |||
| IPSC Century Therapeutics, Inc. - Common Stock | $23.183.480 | 0,34% | 9.462.645 | $1.741.176 | Turun ×1 | ||
| Penerbit tidak dikenal (CUSIP: 370920100) | $22.501.459 | 0,33% | 1.333.815 | Naik ×1 | |||
| VSTM Verastem, Inc. - Common Stock | $21.930.047 | 0,32% | 5.740.850 | $-8.496.458 | |||
| KURA Kura Oncology, Inc. - Common Stock | $21.704.858 | 0,32% | 1.978.565 | $212.862 | Turun ×1 | ||
| ENTA Enanta Pharmaceuticals, Inc. - Common Stock | $21.055.955 | 0,31% | 1.444.167 | $-3.659.275 | Turun ×1 | ||
| NKTR Nektar Therapeutics - Common Stock | $20.943.000 | 0,30% | 300.000 | Naik ×1 | |||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $18.765.000 | 0,27% | 1.500.000 | ||||
| Penerbit tidak dikenal (CUSIP: 482931102) | $15.421.000 | 0,22% | 700.000 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 485925101) | $14.310.000 | 0,21% | 600.000 | Naik ×1 | |||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $11.418.750 | 0,17% | 225.000 | Naik ×1 | |||
| PMN ProMIS Neurosciences Inc. - Common Shares | $10.997.220 | 0,16% | 835.655 | $384.401 | |||
| IMCR Immunocore Holdings plc - American Depositary Shares | $9.881.172 | 0,14% | 311.218 | $-48.365.131 | Turun ×2 | ||
| XNCR Xencor, Inc. - Common Stock | $9.556.171 | 0,14% | 593.551 | ||||
| CNTX Context Therapeutics Inc. - Common Stock | $4.109.581 | 0,06% | 7.419.355 | $-15.329.129 | |||
| IVA Inventiva S.A. - American Depository Shares | $3.024.000 | 0,04% | 800.000 | $-3.760.614 | Turun ×1 | ||
| ALGS Aligos Therapeutics, Inc. - Common stock | $2.562.515 | 0,04% | 444.110 | $-737.222 | |||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| ALNY | $248.349.750 | 825.000 | 3,61% |
| Penerbit tidak dikenal (CUSIP: 423494103) | $132.304.876 | 3.602.093 | 1,93% |
| GHRS | $89.600.018 | 3.333.334 | 1,30% |
| GMAB | $82.410.000 | 3.000.000 | 1,20% |
| UTHR | $66.978.857 | 123.616 | 0,97% |
| AVTX | $66.712.800 | 3.610.000 | 0,97% |
| ALT | $58.520.000 | 19.250.000 | 0,85% |
| WGS | $48.055.000 | 700.000 | 0,70% |
| HROW | $41.153.430 | 969.000 | 0,60% |
| IMMX | $28.610.250 | 2.775.000 | 0,42% |
| STTK | $25.724.734 | 3.706.734 | 0,37% |
| MNKD | $25.560.000 | 6.000.000 | 0,37% |
| Penerbit tidak dikenal (CUSIP: 370920100) | $22.501.459 | 1.333.815 | 0,33% |
| NKTR | $20.943.000 | 300.000 | 0,30% |
| OLMA | $18.765.000 | 1.500.000 | 0,27% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| GH | Beli lebih banyak | +55K | +$200.7M |
| BMRN | Beli lebih banyak | +2.2M | +$124.3M |
| CMPS | Hanya pergerakan harga | +0 | +$104.8M |
| NRIX | Beli lebih banyak | +1.4M | +$89.3M |
| ORKA | Dipangkas | -108K | +$83.5M |
| ALKS | Beli lebih banyak | +410K | +$82.6M |
| NUVL | Beli lebih banyak | +407K | +$79.2M |
| TNGX | Beli lebih banyak | +1.4M | +$73.8M |
| IMVT | Dipangkas | -2.2M | +$73.6M |
| DFTX | Dipangkas | -250K | +$72.7M |
1 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| XBI | 30 Juni 2026 | 10.000.000 | $1.277.300.000 | Tidak lagi dilacak |
| ITCI | 30 Juni 2025 | 2.000.000 | $263.840.000 | Tidak lagi dilacak |
| DVAX | 31 Maret 2026 | 15.726.349 | $241.871.248 | Tidak lagi dilacak |
| AKRO | 31 Des. 2025 | 4.000.978 | $189.966.435 | Tidak lagi dilacak |
| APLS | 30 Juni 2026 | 4.532.374 | $182.337.406 | Tidak lagi dilacak |
| INSM | 30 Sep. 2025 | 1.750.000 | $176.120.000 | -10,9% |
| ETNB | 31 Des. 2025 | 9.356.171 | $137.535.714 | Tidak lagi dilacak |
| CNTA | 30 Juni 2026 | 3.158.041 | $125.437.389 | Tidak lagi dilacak |
| SWTX | 31 Maret 2025 | 3.460.756 | $125.037.114 | Tidak lagi dilacak |
| PTGX | 31 Des. 2025 | 1.715.691 | $113.973.353 | 74,5% |
| BBIO | 30 Juni 2026 | 841.445 | $62.485.706 | 11,8% |
| TERN | 30 Juni 2026 | 1.073.877 | $56.614.795 | Tidak lagi dilacak |
| NMRA | 31 Maret 2025 | 5.189.800 | $55.011.880 | 59,0% |
| EXAS | 31 Des. 2025 | 1.000.000 | $54.710.000 | Tidak lagi dilacak |
| HRMY | 31 Maret 2025 | 1.450.000 | $49.894.500 | 18,9% |
| RARE | 30 Sep. 2025 | 1.350.000 | $49.086.000 | -11,7% |
| GERN | 30 Juni 2026 | 31.720.278 | $47.263.214 | 22,3% |
| ANIP | 30 Juni 2026 | 600.000 | $46.140.000 | -5,8% |
| GMAB | 31 Maret 2025 | 2.000.000 | $41.740.000 | 71,3% |
| DNTH | 30 Sep. 2025 | 2.233.148 | $41.603.547 | 182,1% |
| VRNA | 31 Maret 2025 | 850.000 | $39.474.000 | Tidak lagi dilacak |
| SLNO | 30 Juni 2026 | 1.078.710 | $36.115.211 | Tidak lagi dilacak |
| AMGN | 30 Juni 2025 | 113.035 | $35.216.054 | 56,2% |
| OLMA | 31 Des. 2025 | 3.470.172 | $33.972.984 | -56,2% |
| MTSR | 30 Sep. 2025 | 1.094.408 | $31.135.908 | Tidak lagi dilacak |
| EWTX | 30 Juni 2025 | 1.400.000 | $30.800.000 | 242,1% |
| ENGN | 30 Juni 2026 | 4.377.572 | $29.811.265 | 4,3% |
| CDTX | 31 Des. 2025 | 300.000 | $28.728.000 | Tidak lagi dilacak |
| QURE | 31 Des. 2025 | 483.092 | $28.198.080 | 100,2% |
| TECX | 30 Sep. 2025 | 1.401.938 | $27.856.508 | 130,5% |
| ABVX | 30 Sep. 2025 | 3.480.144 | $26.623.102 | 38,6% |
| APGE | 30 Juni 2026 | 285.000 | $23.988.450 | 1,5% |
| CNTA | 31 Maret 2025 | 1.350.000 | $22.612.500 | Tidak lagi dilacak |
| MNMD | 31 Maret 2026 | 1.676.540 | $22.448.871 | Tidak lagi dilacak |
| DYN | 30 Juni 2025 | 2.000.000 | $20.920.000 | 173,3% |
| JBIO | 31 Des. 2025 | 2.279.892 | $19.675.468 | 40,4% |
| GLPG | 30 Juni 2025 | 741.068 | $18.615.628 | Tidak lagi dilacak |
| GHRS | 31 Des. 2025 | 1.250.000 | $17.875.000 | 131,3% |
| JANX | 30 Juni 2026 | 1.187.290 | $16.503.331 | 13,2% |
| XENE | 31 Maret 2026 | 366.435 | $16.423.617 | 6,0% |
| SAGE | 30 Juni 2025 | 2.038.845 | $16.208.818 | Tidak lagi dilacak |
| UPB | 30 Sep. 2025 | 1.442.767 | $15.841.582 | -61,2% |
| GMAB | 31 Des. 2025 | 481.267 | $14.760.459 | 8,9% |
| MRUS | 30 Sep. 2025 | 275.000 | $14.465.000 | Tidak lagi dilacak |
| SRPT | 30 Sep. 2025 | 709.800 | $12.137.580 | -0,6% |
| BCYC | 30 Sep. 2025 | 1.203.244 | $8.362.546 | -47,6% |
| CBIO | 30 Juni 2026 | 453.686 | $8.334.212 | -6,4% |
| IMA | 31 Des. 2025 | 878.516 | $7.159.905 | -18,1% |
| LRMR | 30 Juni 2026 | 1.500.000 | $6.750.000 | 35,0% |
| CNTA | 30 Sep. 2025 | 500.000 | $6.570.000 | Tidak lagi dilacak |
| XNCR | 31 Des. 2025 | 549.439 | $6.444.919 | 75,0% |
| HELP | 30 Juni 2026 | 1.313.137 | $6.303.058 | 85,0% |
| NVAX | 30 Sep. 2025 | 998.542 | $6.290.815 | -3,6% |
| MNPR | 31 Maret 2026 | 95.408 | $6.230.142 | 118,5% |
| BEAM | 30 Juni 2025 | 315.765 | $6.166.890 | 62,0% |
| IVVD | 30 Sep. 2025 | 8.585.980 | $6.138.976 | -10,5% |
| RGLS | 30 Juni 2025 | 3.262.564 | $5.709.487 | Tidak lagi dilacak |
| BHVN | 31 Maret 2026 | 500.000 | $5.645.000 | 64,4% |
| PEPG | 31 Des. 2025 | 1.200.000 | $5.544.000 | -52,1% |
| PLRX | 30 Sep. 2025 | 3.947.807 | $4.579.456 | -20,9% |
| AUTL | 31 Des. 2025 | 2.568.613 | $4.186.839 | 24,1% |
| INO | 30 Sep. 2025 | 1.981.370 | $4.032.088 | -46,2% |
| BLLN | 30 Juni 2026 | 50.000 | $3.947.000 | -22,3% |
| RAPT | 31 Maret 2026 | 110.448 | $3.740.874 | Tidak lagi dilacak |
| KRRO | 30 Sep. 2025 | 277.966 | $3.471.795 | -71,8% |
| FDMT | 31 Maret 2025 | 609.900 | $3.397.143 | 386,2% |
| IKNA | 30 Sep. 2025 | 2.515.513 | $3.370.787 | Tidak lagi dilacak |
| SYRE | 30 Sep. 2025 | 219.015 | $3.278.655 | 532,2% |
| ACAD | 31 Des. 2025 | 105.085 | $2.242.514 | 11,5% |
| AVTX | 31 Des. 2025 | 144.600 | $1.837.866 | 11,6% |
| NKTR | 31 Maret 2025 | 1.975.998 | $1.837.678 | 633,4% |
| ALLK | 30 Juni 2025 | 7.232.701 | $1.646.163 | Tidak lagi dilacak |
| NGNE | 30 Juni 2025 | 116.660 | $1.366.089 | 150,9% |
| SEPN | 30 Sep. 2025 | 121.716 | $1.286.538 | 129,9% |
| SAVA | 31 Maret 2025 | 500.000 | $1.180.000 | Tidak lagi dilacak |
| ZURA | 31 Des. 2025 | 259.014 | $1.121.531 | 9,2% |
| RAPP | 30 Sep. 2025 | 98.237 | $1.116.955 | 63,7% |
| CLYM | 31 Des. 2025 | 509.789 | $1.024.676 | 328,3% |
| OKUR | 30 Sep. 2025 | 180.510 | $431.419 | 44,7% |
| ANL | 31 Maret 2026 | 34.852 | $49.490 | 102,6% |